Rabbit anti-human T-lymphocyte globulin

Known as: Rabbit Anti-Human THymocyte Globulin (RATG), rATG, Lapine T-Lymphocyte Immune Globulin 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1935-2018
0204019352017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Rabbit antithymocyte globulin (rATG; thymoglobulin, Genzyme) in combination with cyclosporine, as first-line immunosuppressive… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND There are few comparisons of antibody induction therapy allowing early glucocorticoid withdrawal in renal-transplant… (More)
  • figure 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Depletional induction therapies are routinely used to prevent acute rejection and improve transplant outcome. The effects of… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
The best antithymocyte globulin preparation for first-line immune suppression in patients with severe aplastic anemia is still… (More)
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Regulatory T cells (Treg) play important roles in suppressing immune responses and maintaining tolerance. Rabbit antithymocyte… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
We have reported a lower incidence of acute graft-versus-host disease (aGVHD) with a novel conditioning regimen using low-dose… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Induction therapy reduces the frequency of acute rejection and delayed graft function after transplantation. A rabbit… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Polyclonal antithymocyte globulin (ATG) is widely used as an anti-T-cell agent for induction and treatment of acute… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
New conditioning regimens are being explored to reduce toxicity and enable allogeneic bone marrow transplantation in patients not… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Immunosuppression has recently been proposed for low-risk myelodysplastic syndromes (MDS) to reverse bone marrow failure by… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?